Ying Wang is a Senior Scientist at Merck, where they currently lead innovative research initiatives. Previously, they served as a Scientist at Regeneron and as a Research Associate at the University of North Carolina at Chapel Hill, focusing on advanced gene therapies and cancer immunotherapy. Ying gained valuable experience as an intern at OncoTrap Inc. and as a Visiting PhD Student at Peking University, where they worked on overcoming gastrointestinal barriers with modified nanoplatforms. Ying holds a PhD in Pharmaceutical Sciences from Shenyang Pharmaceutical University, which they completed in 2017.
This person is not in the org chart
This person is not in any teams
This person is not in any offices